RICHARD KIMANI: Open Payments
NPI 1417951849 · MCMINNVILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 39 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $6,088 · 2025 $844
Food & beverage: $824Education: $20
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $142 |
| PFIZER INC. | 6 | $127 |
| Madrigal Pharmaceuticals | 3 | $111 |
| Exact Sciences Corporation | 2 | $46 |
| Novo Nordisk Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: EVENITY, REZDIFFRA, ELIQUIS, The Cologuard Plus Collection Kit, Kerendia, XIFAXAN, REXULTI, INGREZZA.
Industry payments across OR — which companies pay providers there.
